Explore the complexities of Ulcerative Colitis, its causes, diagnostic methods, and breakthrough treatments for better ...

The University of Central Lancashire is co-leading the first and largest human trial of its kind. A study found that patients ...

J&J’s guselkumab gets EU approval for ulcerative colitis, offering new hope for patients who don’t respond to current ...

Johnson & Johnson (J&J) has announced that its dual-acting IL-23 inhibitor Tremfya (guselkumab) has been approved by the ...

Appendicectomy combined with standard medical therapy is superior to standard medical therapy alone in maintaining remission ...

People with the condition should seek emergency medical help if their treatments stop working or if symptoms become more frequent or severe. Ulcerative colitis is a type of IBD that causes ...

Have you ever found yourself in a situation where, despite your best efforts, your Ulcerative Colitis (UC) symptoms flare up unexpectedly? UC, a chronic inflammatory bowel disease, can be ...

QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services ...

Following the study, the FDA approved the use of Tremfya to treat moderately to severely active ulcerative colitis. In September 2024, the University of Chicago Medicine became the first hospital in ...

Appendectomy may be a useful addition to medical therapy for preventing relapse of ulcerative colitis among patients in ...